Publications
Filters: First Letter Of Last Name is W [Clear All Filters]
“Genomic surveillance for hypervirulence and multi-drug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia”, Genome Med, vol. 12, no. 1, p. 11, 2020.
, “Extreme neonatal hyperbilirubinaemia in refugee and migrant populations: retrospective cohort”, BMJ Paediatrics Open, vol. 4, no. 1, p. e000641, 2020.
, “High-throughput analysis of antimalarial susceptibility data by the WWARN In Vitro Analysis and Reporting Tool (IVART)”, Antimicrob Agents Chemother, 2013.
, “Comparison between Flow Cytometry, Microscopy, and Lactate Dehydrogenase-Based Enzyme-Linked Immunosorbent Assay for Plasmodium falciparum Drug Susceptibility Testing under Field Conditions”, J Clin Microbiol, vol. 53, no. 10, pp. 3296-303, 2015.
, “Melioidosis in Myanmar”, Trop Med Infect Dis, vol. 3, no. 1, 2018.
, “Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach”, PLoS Med, vol. 12, no. 4, p. e1001823, 2015.
, “Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine”, Clin Pharmacokinet, vol. 37, no. 2, pp. 105-25., 1999.
, “Artesunate versus quinine for severe falciparum malaria - Authors' reply”, Lancet, vol. 367, no. 9505, pp. 111-112, 2006.
, “High initiation and long duration of breastfeeding despite absence of early skin-to-skin contact in Karen refugees on the Thai-Myanmar border: a mixed methods study”, Int Breastfeed J, vol. 7, no. 1, p. 19, 2012.
, “Averting a malaria disaster”, The Lancet, vol. 353, no. 9168, pp. 1965-1967, 1999.
, “Spiroindolone KAE609 for falciparum and vivax malaria”, N Engl J Med, vol. 371, no. 5, pp. 403-10, 2014.
, “Comparison of artemether and chloroquine for severe malaria in Gambian children”, Lancet, vol. 339, pp. 317-21, 1992.
, “Averting a malaria disaster (reply)”, The Lancet, vol. 354, no. 9187, pp. 1389-1390, 1999.
, “Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria”, Malar J, vol. 13, no. 1, p. 483, 2014.
, “New Medicines for Tropical Diseases in Pregnancy: Catch-22”, PLoS Medicine, vol. 5, no. 6, p. e133, 2008.
, “Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria”, N Engl J Med, vol. 375, no. 12, pp. 1152-60, 2016.
, “Estimation of gestational age from fundal height: a solution for resource-poor settings”, J R Soc Interface, vol. 9, no. 68, pp. 503-510, 2012.
, “WHO, the Global Fund, and medical malpractice in malaria treatment”, Lancet, vol. 363, no. 9415, p. 1160, 2004.
, “Accelerated Training of Skilled Birth Attendants in a Marginalized Population on the Thai-Myanmar Border: A Multiple Methods Program Evaluation”, PLoS One, vol. 11, no. 10, p. e0164363, 2016.
, “Toxic brainstem encephalopathy after artemisinin treatment for breast cancer”, Ann Neurol, vol. 59, no. 4, pp. 725-6, 2006.
, “Evaluation of a surgical service in the chronic phase of a refugee camp: an example from the Thai-Myanmar border”, Conflict and Health, vol. 6, no. 1, p. 5, 2012.
, “A prospective evaluation of diagnostic methodologies for the acute diagnosis of dengue virus infection on the Thailand-Myanmar border”, Trans R Soc Trop Med Hyg, vol. 105, no. 1, pp. 32-7, 2011.
, “Scrub typhus infection in pregnancy: the dilemma of diagnosis and treatment in a resource-limited setting”, Clinical Case Reports, p. n/a-n/a, 2016.
, “Diagnostic Accuracy Assessment of Immunochromatographic Tests for the Rapid Detection of Antibodies Against Orientia tsutsugamushi Using Paired Acute and Convalescent Specimens”, Am J Trop Med Hyg, vol. 93, no. 6, pp. 1168-71, 2015.
, “A Prospective Evaluation of Real-Time PCR Assays for the Detection of Orientia tsutsugamushi and Rickettsia spp. for Early Diagnosis of Rickettsial Infections during the Acute Phase of Undifferentiated Febrile Illness”, Am J Trop Med Hyg, 2013.
, “Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria”, PLoS neglected tropical diseases, vol. 12, no. 4, p. e0006440, 2018.
, “Characterising blood stage antimalarial drug minimum inhibitory concentrations in vivo using reinfection patterns”, Antimicrobial agents and chemotherapy, pp. AAC. 02476-17, 2018.
, “Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance”, Lancet Infect Dis, vol. 7, no. 2, pp. 136-44, 2007.
, “Single dose pharmacokinetics of proguanil and its metabolites in pregnancy”, European Journal of Clinical Pharmacology, vol. 44, no. 3, pp. 247-51, 1993.
, “Multiple displacement amplification for malaria parasite DNA”, J Parasitol, vol. 95, no. 1, pp. 253-5, 2009.
, “Intracranial pressure in childhood cerebral malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 85, no. 3, pp. 362-4, 1991.
, “Clinical features and outcome of severe malaria in Gambian children”, Clinical Infectious Diseases, vol. 21, no. 3, pp. 577-87, 1995.
,